Принципы лучевой терапии рака гортани

Лучевая терапия широко применяется как один из основных методов специфического лечения рака гортани. В настоящее время радиотерапевтическая техника для лечения больных раком головы и шеи представлена в основном линейными ускорителями электронов, способными создать индивидуальные, сложные конфигурации объемов облучения. В статье описаны новые технологии лучевой терапии заболевания на ранних и местно-распространенных стадиях, принципы органосохраняющего лечения при опухолях гортани, показания к пред- и послеоперационному облучению, методы профилактики посттерапевтических осложнений.

1. Mendenhall W.M., Werning J.W., Hinerman R.W. et al. Management of T1-T2 glottic carcinomas. Cancer 2004;100:1786-92. DOI: 10.1002/cncr.20181.

2. Chera B.S., Amdur R.J., Morris C.G. et al. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:461-6. DOI: 10.1016/j.ijrobp.2009.08.066.

3. Пачес А.И. Опухоли головы и шеи. М.: Медицина, 2001.

4. Lederman M. The place of radiotherapy in the treatment of cancer of the larynx. Ann Radiol (Paris) 1961;4:433-54. DOI: 10.1136/bmj.1.5240.1639.

5. The International Commission on Radiation Units and Measurements. J ICRU 2010;10(2):5—6. DOI: 10.1093/jicru/ndq025.

6. Yamazaki H., Suzuki G., Nakamura S. et al. Radiotherapy for laryngeal cancer — technical aspects and alternate fractionation. J Radiat Res 2017;58(4):495—508. DOI: 10.1093/jrr/rrx023.

7. Chera B.S., Amdur R.J., Morris C.G. et al. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2010;78(2):461-6. DOI: 10.1016/j.ijrobp.2009.08.066.

8. Tamura Y., Tanaka S., Asato R. et al. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years. Acta Otolaryngol Suppl 2007;(557):62—5. DOI: 10.1080/00016480601067990.

9. Blanch J.L., Vilaseca I., Caballero M. et al. Outcome of transoral laser microsurgery for T2-T3 tumors growing in the laryngeal anterior commissure. Head Neck 2011;33(9):1252-9. DOI: 10.1002/hed.21605.

10. Aaltonen L.M., Rautiainen N., Sellman J. et al. Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy. Int J Radiat Oncol Biol Phys 2014;90(2):255-60. DOI: 10.1016/j.ijrobp.2014.06.032.

11. Higgins K.M., Shah M.D., Ogaick M.J., Enepekides D. Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg 2009;38(6):603. DOI: 10.2310/7070.2009.080235.

12. Amdur R.J., Parsons J.T., Mendenhall W.M. et al. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989;16:25-36. DOI: 10.1016/0360-3016(89)90006-0.

13. Wolf G.Y., Fisher S.G., Hong W.K. et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324(24):1685-90. DOI: 10.1016/0196-0709(91)90133-z.

14. Forastiere A.A., Goepfert H., Maor M. et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349(22):2091-8.

15. Mendenhall W.M., Amdur R.J., Morris C.G. et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19:4029-36. DOI: 10.1200/jco.2001.19.20.4029.

16. Yamazaki H., Nishiyama K., Tanaka E. et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 2006;64:77-82.

17. Megan E.D., Le Q.T., Jain A.K. et al. Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head Neck 2011;33:103-11. DOI: 10.1016/j.ijrobp.2005.06.014.

18. Practical Radiation Oncology. Ed. by S. Mallick, G.K. Rath, R. Benson. Singapore: Springer, 2020. 300 p. DOI: 10.1007/978-981-15-0073-2.

19. Mendenhall W.M., Riggs C.E., Cassisi N.J. Treatment of head and neck cancers. In: DeVita, Hellman, and Rosenberg’s Cancer: principles and practice of oncology. Ed. by V.T. DeVita, S. Hellman, S.A. Rosenberg. Philadelphia: Lippincott Williams & Wilkins, 2008. Pp. 809-814. DOI: 10.1007/3-540-35665-7_18.

20. Gourin C.G., Conger B.T., Sheils W.C. et al. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009;119:1312-7. DOI: 10.1002/lary.20477.

21. Hinerman R.W., Mendenhall W.M., Amdur R.J. et al. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002;24:456-67. DOI: 10.1002/hed.10069.

22. Bernier J., Cooper J.S., Pajak T.F. et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27(10):843-50. DOI: 10.1002/hed.20279.

23. Cooper J.S., Zhang O., Pajak T.F. et al. Long-term follow-up of the RTOG 9501/ intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;84(5):1198—205. DOI: 10.1016/j.ijrobp.2012.05.008.

24. Amdur R.J., Parsons J.T., Mendenhall WM. et al. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989;16:25-36. DOI: 10.1016/0360-3016(89)90006-0.

25. Forastiere A.A., Zhang Q., Weber R.S. et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013;31(7):845-52. DOI: 10.1200/jco.2012.43.6097.

26. Hoffman H.T., Porter K., Karnell L.H. et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:1-13. DOI: 10.1097/01.mlg.0000236095.97947.26.

27. Dziegielewski P.T., O’Connell D.A., Klein M. et al. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 2012;41 Suppl 1:S56-64. DOI: 10.2310/7070.2011.110081.

28. Megwalu U.C., Sikora A.G. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg 2014;140:855-60. DOI: 10.1001/jamaoto.2014.1671.

29. Ткачев С.И., Матякин Е.Г., Любаев В.Л. и др. Сравнительная оценка пятилетних результатов хирургического, комбинированного, лучевого и химиолучевого методов лечения рака гортани в стадии T3N0M0. Вопросы онкологии 2006;52(4):404-8.

30. Mendenhall W.M., Morris C.G.,Amdur R.J. et al. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003;25:535-42. DOI: 10.1002/hed.10253.

31. Клинические рекомендации по лечению опухолей гортани под редакцией Ассоциации онкологов России и Российского общества специалистов по опухолям головы и шеи. Доступно по: https://oncology-association.ru/files/clinical-guidelines-2020/Rak_gortani.pdf.

32. Specenier P., Vermorken J.B Cetuximab: its unique place in head and neck cancer treatment. Biologics 2013;7:77-90. DOI: 10.2147/btt.s43628.

33. Al-Othman M.O., Amdur R.J., Morris C.G. et al. Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer? Head Neck 2003;25:741-7. DOI: 10.1002/hed.10279.